These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17566141)

  • 1. Interval estimation of binomial proportion in clinical trials with a two-stage design.
    Tsai WY; Chi Y; Chen CM
    Stat Med; 2008 Jan; 27(1):15-35. PubMed ID: 17566141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On Simon's two-stage design for single-arm phase IIA cancer clinical trials under beta-binomial distribution.
    Liu J; Lin Y; Shih WJ
    Stat Med; 2010 May; 29(10):1084-95. PubMed ID: 20077506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stochastically curtailed phase II clinical trials.
    Ayanlowo AO; Redden DT
    Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admissible two-stage designs for phase II cancer clinical trials.
    Jung SH; Lee T; Kim K; George SL
    Stat Med; 2004 Feb; 23(4):561-9. PubMed ID: 14755389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the estimation of the binomial probability in multistage clinical trials.
    Jung SH; Kim KM
    Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive two-stage designs in phase II clinical trials.
    Banerjee A; Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curtailed two-stage designs in Phase II clinical trials.
    Chi Y; Chen CM
    Stat Med; 2008 Dec; 27(29):6175-89. PubMed ID: 18816510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trials with a prospective control.
    Jung SH
    Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size tables for exact single-stage phase II designs.
    A'Hern RP
    Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confidence interval construction for proportion difference in small-sample paired studies.
    Tang ML; Tang NS; Chan IS
    Stat Med; 2005 Dec; 24(23):3565-79. PubMed ID: 16261646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence intervals for the binomial parameter: some new considerations.
    Reiczigel J
    Stat Med; 2003 Feb; 22(4):611-21. PubMed ID: 12590417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stopping clinical trials of binomial response with an exact group sequential method.
    Zhao Z
    Stat Med; 2007 Apr; 26(8):1724-9. PubMed ID: 17206748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parameter estimation following an adaptive treatment selection trial design.
    Luo X; Wu SS; Xiong J
    Biom J; 2010 Dec; 52(6):823-35. PubMed ID: 21154898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Samples of exact k-stage group sequential designs for Phase II and Pilot studies.
    Kepner JL; Chang MN
    Control Clin Trials; 2004 Jun; 25(3):326-33. PubMed ID: 15157732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exact method for analysis following a two-stage phase II cancer clinical trial.
    Jovic G; Whitehead J
    Stat Med; 2010 Dec; 29(30):3118-25. PubMed ID: 21170906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balanced two-stage designs for phase II clinical trials.
    Ye F; Shyr Y
    Clin Trials; 2007; 4(5):514-24. PubMed ID: 17942467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stage k-sample designs for the ordered alternative problem.
    Shan G; Hutson AD; Wilding GE
    Pharm Stat; 2012; 11(4):287-94. PubMed ID: 22408050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How a new stratified adaptive phase II design could improve targeting population.
    Tournoux-Facon C; De Rycke Y; Tubert-Bitter P
    Stat Med; 2011 Jun; 30(13):1555-62. PubMed ID: 21432892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A flexible multi-stage design for phase II oncology trials.
    Tan MT; Xiong X
    Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.